Machine learning-predicted insulin resistance is a risk factor for 12 types of cancer

· Source: Machine learning : nature.com subject feeds · Field: Science & Research — Health & Medical Research, Life Sciences & Biology, Mathematics & Computational Sciences · Depth: Advanced, extended

Summary

A machine learning model, artificial intelligence–derived insulin resistance (AI-IR), predicts insulin resistance using nine clinical parameters and identifies it as a significant risk factor for 12 types of cancer. Applied to the UK Biobank cohort, AI-IR demonstrated superior predictive performance for diabetes incidence (AUC 0.798) compared to traditional metrics like BMI (0.721), metabolic syndrome (0.748), TG/HDL ratio (0.702), and TyG index (0.703). The study found AI-IR to be significantly associated with an increased risk of six cancers (uterine, kidney, esophagus, pancreas, colon, and breast) and nominally associated with six others (renal pelvis, small intestine, stomach, liver and gallbladder, leukemia, and bronchial and lung). For composite cancers, the age- and sex-adjusted hazard ratio for AI-IR positive individuals without diabetes was 1.25 (95% CI, 1.20-1.31; P < 1 × 10⁻¹¹). AI-IR also improved cancer risk stratification, even for individuals with obesity.

Key takeaway

For AI Scientists developing predictive health models, this research highlights the value of machine learning in identifying complex disease risk factors like insulin resistance. Your models can integrate multiple clinical parameters to create more robust "digital biomarkers" that surpass traditional metrics. Consider how your predictive tools can capture both BMI-dependent and BMI-independent effects to enhance risk stratification for conditions like diabetes and cancer, leading to more targeted clinical interventions and improved patient outcomes.

Key insights

AI-IR, a machine learning model, robustly predicts insulin resistance and identifies it as a risk factor for 12 cancer types.

Principles

Method

An XGBoost model was trained on nine clinical parameters to predict HOMA-IR > 2.5, achieving an AUC of 0.88. This AI-IR model was then applied to the UK Biobank to assess disease incidence.

In practice

Topics

Best for: AI Scientist, AI Researcher, Data Scientist, Research Scientist

Related on AIssential

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Machine learning : nature.com subject feeds.